Observational Triveneto Study on the Use of Adjuvant Hormonal Therapies in the Treatment of Hormone-responsive Breast Cancer
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Post Menopausal|Breast Cancer
Sponsor: AstraZeneca